PMID: 6175410Mar 1, 1982Paper

The renal toxicity of cancer chemotherapeutic agents

Cancer Treatment Reviews
R B Weiss, D S Poster


No abstract listed.


Aug 1, 1979·International Journal of Radiation Oncology, Biology, Physics·D LehaneY Daskal
Sep 20, 1979·The New England Journal of Medicine·J J BakerM Chang
Feb 1, 1976·Proceedings of the Society for Experimental Biology and Medicine·N RakietenR L Dixon
Dec 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·R F Borch, M E Pleasants
Jun 1, 1979·Annals of Internal Medicine·R L Schilsky, T Anderson
Mar 1, 1979·Cancer Treatment Reviews·A W PrestaykoS T Crooke
May 24, 1979·The New England Journal of Medicine·W E HarmonW E Grupe
Nov 22, 1979·The New England Journal of Medicine·W C Nichols, C G Moertel
Jan 1, 1976·Medical and Pediatric Oncology·E Frei
Apr 1, 1977·Cancer·J C Gonzales-VitaleS S Sternberg
Oct 1, 1974·Cancer·W T HardakerR McCoy
Feb 1, 1972·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S K Carter, M A Friedman
Dec 9, 1972·British Medical Journal·M G Dahl, J S Comaish
Feb 1, 1974·Cancer·R A DeFronzoP J Davis
Nov 1, 1971·Cancer·K LiuE G Elias
Jun 1, 1971·Annals of Internal Medicine·R L CapizziR E Handschumacher
Jan 1, 1969·Cancer·P T ConditW Joel
Feb 1, 1966·Cancer·L H Manheimer, J Vital
Feb 1, 1967·The British Journal of Dermatology·A W McKenzie, C V Aitken
Sep 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·R F BorchM E Pleasants
Dec 15, 1981·Cancer·W T HannaW M Murphy
Mar 1, 1980·The American Journal of Medicine·E FreiG P Canellos
Sep 15, 1981·Cancer·R G SchachtD S Baldwin

❮ Previous
Next ❯


Jan 1, 1990·Cancer Chemotherapy and Pharmacology·G Singh, E Maniccia-Bozzo
Jan 1, 1989·Pharmacology & Therapeutics·A C Smith
Dec 1, 1982·Cancer Treatment Reviews·R B Weiss, B F Issell
Apr 1, 1988·Baillière's Clinical Gastroenterology·K Ewe
Nov 1, 1986·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·F Ries, J Klastersky
Jan 31, 2009·Veterinary and Comparative Oncology·K BarabasC Adin
Jun 3, 1998·Chemico-biological Interactions·L Dalla ViaR Deana
Sep 1, 1983·Cancer Treatment Reviews·D C Doll, R B Weiss
Apr 1, 1987·European Journal of Cancer & Clinical Oncology·O MellaO D Laerum
Jun 1, 1988·European Journal of Cancer & Clinical Oncology·F Ries
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A LaquerriereJ Hemet
Feb 14, 2006·Seminars in Oncology·Nasir ShahabDonald C Doll
Feb 1, 1987·International Journal of Andrology·R SafirsteinJ Guttenplan
Jan 1, 1986·Toxicologic Pathology·H TanakaE Shimizu
Oct 1, 1985·Cancer·J J OffermanE G de Vries
Jan 1, 1985·Critical Reviews in Toxicology·S Garattini
Jan 1, 1985·Drug Intelligence & Clinical Pharmacy·L J PietruszkaP H Vlasses
Nov 27, 2020·Frontiers in Chemistry·Cerise M SiamofWeibo Cai

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The American Journal of Medicine
E GoffinC M Lockwood
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
D GandiaP Rougier
© 2021 Meta ULC. All rights reserved